PR3-AAV Resilient Remission or PRRR

计划入组 6 人 · 首次发布于 2022 年 5 月 17 日

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

计划入组 31 人 · 首次发布于 2019 年 5 月 30 日

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

计划入组 361 人 · 首次发布于 2003 年 1 月 27 日

PR300

PJ3

P13

PRO-IMPLANT Foundation

Germany

PRP CONCEPTS LLC

United States

PRM PHARMA, LLC

United States

Amgen's Tavneos Enters Phase 3 Trial for Pediatric ANCA-Associated Vasculitis

AliveDx Advances MosaiQ Platform in US Market with FDA Device Registration and Vasculitis Test Submission

CT-P13 Subcutaneous Formulation Shows Comparable Pharmacokinetics and Safety via Autoinjector and Pre-filled Syringe